Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2021 Fall Conference | Industry Therapeutic Update from Novartis: KESIMPTA: Flexibility of a Self-Administered RMS Therapy

Friday 11/05/21
11:30 AM - 12:00 PM EDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Industry Therapeutic Update
David Hojnacki, MD, FÂ鶹´«Ã½Ó³»­
No CME available

Program Materials Program Evaluations

Event Timeline
11:30 AM - 12:00 PM EDT Speaker Industry Therapeutic Update from Novartis: KESIMPTA: Flexibility of a Self-Administered RMS Therapy
Faculty Disclosures
David Hojnacki, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hojnacki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.